Thyroid Cancer -
-30% with code BOOKS
Shipping in 12-18 days
30-day return policy
The American Cancer Society recently estimated that about 45,000 new cases of thyroid cancer will be diagnosed in the United States, with three-quarters occurring in women. The overall 5-year survival rate is about 97%, making it one of the least lethal cancers. We are experiencing an epidemic of well-differentiated thyroid cancer, in part due to the widespread use of imaging modalities that detect thyroi ... Full description
You May Also Like
TOP
The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture
-30% with code BOOKS
In stock
TOP
The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma
-30% with code BOOKS
In stock at our supplier
TOP
No Bad Parts: Healing Trauma and Restoring Wholeness with the Internal Family Systems Model
-30% with code BOOKS
In stock at our supplier
TOP
On Connection: 'Powerful' MATT HAIG
-30% with code BOOKS
In stock at our supplier
TOP
Oxford Handbook of Clinical Medicine
Peter Hateley, Iain McGurgan, Ian B. Wilkinson, Tim Raine, Dearbhla Kelly, Kate Wiles
-30% with code BOOKS
In stock at our supplier
TOP
Harrison's Principles of Internal Medicine (Vol.1 & Vol.2)
Stephen Hauser, Joseph Loscalzo, Steven Holland, Dan Longo, J. Larry Jameson, Dennis Kasper, Carol Langford, Anthony Fauci
-30% with code BOOKS
In stock at our supplier
TOP
The Checklist Manifesto: How to Get Things Right
-30% with code BOOKS
In stock at our supplier
TOP
Maybe You Should Talk to Someone: a therapist, her thearapist, and our lives revealed
-30% with code BOOKS
In stock at our supplier
TOP
How Not To Die: Discover the foods scientifically proven to prevent and reverse disease
-30% with code BOOKS
In stock at our supplier
TOP
Vademecum Metabolicum: Diagnosis and Treatment of Inborn Errors of Metabolism Forword by William L. Nyhan, San Diego, USA
Johannes Zschocke, Georg F. Hoffmann
-30% with code BOOKS
In stock at our supplier
TOP
Cellular and Molecular Immunology
Sarah Henrickson, Abul K. Abbas, Andrew H. Lichtman, Shiv Pillai
-30% with code BOOKS
In stock at our supplier
TOP
McGee's Evidence-Based Physical Diagnosis
-30% with code BOOKS
In stock at our supplier
TOP
Physics, Pharmacology and Physiology for Anaesthetists: Key Concepts for the FRCA
Matthew E. Cross, Emma V. E. Plunkett
-30% with code BOOKS
In stock at our supplier
TOP
Being Mortal: Medicine and What Matters in the End
-30% with code BOOKS
In stock at our supplier
TOP
Pocket Guide to Teaching for Clinical Instructors
-30% with code BOOKS
In stock at our supplier
TOP
Oxford Handbook of Critical Care
Andrew Webb, Mervyn Singer, Alice Carter
-30% with code BOOKS
In stock at our supplier
TOP
The Wills Eye Manual: Print + eBook with Multimedia: Office and Emergency Room Diagnosis and Treatment of Eye Disease
-30% with code BOOKS
In stock at our supplier
Description
The American Cancer Society recently estimated that about 45,000 new cases of thyroid cancer will be diagnosed in the United States, with three-quarters occurring in women. The overall 5-year survival rate is about 97%, making it one of the least lethal cancers. We are experiencing an epidemic of well-differentiated thyroid cancer, in part due to the widespread use of imaging modalities that detect thyroid nodules and microcarcinomas. Concurrently, there have been a number of recent advances in surgical treatment, as well as diagnostic modalities that allow us to detect small amounts of residual local and metastatic disease. Additionally, a reexamination of past treatment regimens has led to new recommendations regarding the use of radioactive iodine, and to new therapeutic options, such as targeted therapy which have supplanted the use of more toxic chemotherapy for metastatic cancer. Multiple academic organizations have developed consensus guidelines for the management of thyroid cancer, occasionally with conflicting recommendations. In Thyroid Cancer, a renowned group of authors presents a broad overview of the pathology, pathophysiology, diagnosis, and management of thyroid cancer, with an emphasis on recent evidence-based information. State-of-the-art and a significant contribution to the literature, Thyroid Cancer is an invaluable reference for endocrinologists, oncologists, nuclear medicine physicians, radiation oncologists, primary care physicians, and surgeons who deal with head and neck cancer.
More Information
| Publisher | Springer New York |
|---|---|
| Series | Endocrine Updates |
| Release year | 2016 |
| Cover type | Softcover |
| EAN | 9781489977984 |